Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 2/2018

01-07-2018

Outcome of slow pathway modulation for atrioventricular nodal reentrant tachycardia with 50 versus 30 watts—more power, more effect?

Authors: Dirk G. Dechering, Ruben Schleberger, Eva Greiser, Jannis Dickow, Julia Koebe, Gerrit Frommeyer, Stephan Willems, Lars Eckardt, Boris A. Hoffmann, Kristina Wasmer

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 2/2018

Login to get access

Abstract

Purpose

Slow pathway modulation is the treatment of choice in patients with atrioventricular nodal reentrant tachycardia (AVNRT). No comparative data on ablation strategies exist. Therefore, we sought to compare two common ablation approaches.

Methods

We analyzed prospective ablation databases of two high-volume tertiary centers (> 1000 ablations/year) using either 30 or 50 W for slow pathway modulation from 2012 to 2013. We analyzed procedural characteristics as well as short- and long-term outcomes. Mean follow-up was 36 ± 9 months.

Results

Six hundred thirty-four patients (50 W center: n = 342, 30 W center: n = 292) were ablated. Slow pathway modulation was successful in 99% in both groups (p = ns). Periprocedural AV block occurred in nine patients (2.6%) in the 50 W and five patients (1.7%) in the 30 W group (p = 0.59), respectively. We documented no permanent higher-degree AV block. The number of RF lesions and seconds of RF delivery was significantly less in the 50 W group (p = 0.04 for number of lesions; p < 0.001 for seconds). AVNRT recurrence was similar (p = 0.23). In males, significantly fewer recurrences accrued in the 50 W group (p = 0.04), while in females less transient AV blocks occurred during the procedure with 30 W (p = 0.07).

Conclusions

The 30 and 50 W target power approaches for slow pathway modulation are highly effective and safe. Significantly, fewer RF duration was necessary to modulate the slow pathway with higher power output (50 W). Our subgroup analysis suggests that males and females might benefit most from different modulation approaches.
Literature
1.
go back to reference Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42(8):1493–531.CrossRefPubMed Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42(8):1493–531.CrossRefPubMed
2.
go back to reference Katritsis DG, Zografos T, Katritsis GD, Giazitzoglou E, Vachliotis V, Paxinos G, Camm AJ, Josephson ME. Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. Europace. 2017;19(4):602–606PubMed Katritsis DG, Zografos T, Katritsis GD, Giazitzoglou E, Vachliotis V, Paxinos G, Camm AJ, Josephson ME. Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. Europace. 2017;19(4):602–606PubMed
5.
go back to reference Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. Circulation. 1999;99(2):262–70.CrossRefPubMed Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. Circulation. 1999;99(2):262–70.CrossRefPubMed
7.
go back to reference Strickberger SA, Zivin A, Daoud EG, Bogun F, Harvey M, Goyal R, et al. Temperature and impedance monitoring during slow pathway ablation in patients with AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 1996;7(4):295–300.CrossRefPubMed Strickberger SA, Zivin A, Daoud EG, Bogun F, Harvey M, Goyal R, et al. Temperature and impedance monitoring during slow pathway ablation in patients with AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 1996;7(4):295–300.CrossRefPubMed
8.
go back to reference Willems S, Shenasa H, Kottkamp H, Chen X, Hindricks G, Yli-Mayry S, et al. Temperature-controlled slow pathway ablation for treatment of atrioventricular nodal reentrant tachycardia using a combined anatomical and electrogram guided strategy. Eur Heart J. 1996;17(7):1092–102.CrossRefPubMed Willems S, Shenasa H, Kottkamp H, Chen X, Hindricks G, Yli-Mayry S, et al. Temperature-controlled slow pathway ablation for treatment of atrioventricular nodal reentrant tachycardia using a combined anatomical and electrogram guided strategy. Eur Heart J. 1996;17(7):1092–102.CrossRefPubMed
9.
go back to reference Pott C, Wegner FK, Bogeholz N, Frommeyer G, Dechering DG, Zellerhoff S, et al. Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 2015;104(11):946–54. https://doi.org/10.1007/s00392-015-0862-z. CrossRef Pott C, Wegner FK, Bogeholz N, Frommeyer G, Dechering DG, Zellerhoff S, et al. Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 2015;104(11):946–54. https://​doi.​org/​10.​1007/​s00392-015-0862-z.​ CrossRef
13.
go back to reference Wasmer K. Patients’ and procedural characteristics of AV-block during slow pathway modulation for AVNRT—single center 10 year experience. Submitted. 2017. Wasmer K. Patients’ and procedural characteristics of AV-block during slow pathway modulation for AVNRT—single center 10 year experience. Submitted. 2017.
14.
go back to reference Heydari A, Tayyebi M, Jami RD, Amiri A. Role of isoproterenol in predicting the success of catheter ablation in patients with reproducibly inducible atrioventricular nodal reentrant tachycardia. Texas Heart Institute journal / from the Texas Heart Institute of St Luke's Episcopal Hospital, Texas Children's Hospital. 2014;41(3):280–5. https://doi.org/10.14503/THIJ-13-3332.CrossRef Heydari A, Tayyebi M, Jami RD, Amiri A. Role of isoproterenol in predicting the success of catheter ablation in patients with reproducibly inducible atrioventricular nodal reentrant tachycardia. Texas Heart Institute journal / from the Texas Heart Institute of St Luke's Episcopal Hospital, Texas Children's Hospital. 2014;41(3):280–5. https://​doi.​org/​10.​14503/​THIJ-13-3332.CrossRef
15.
go back to reference Wutzler A, Huemer M, Boldt LH, Parwani AS, Attanasio P, Tscholl V, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2013;15(7):1019–24. https://doi.org/10.1093/europace/eut025.CrossRef Wutzler A, Huemer M, Boldt LH, Parwani AS, Attanasio P, Tscholl V, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2013;15(7):1019–24. https://​doi.​org/​10.​1093/​europace/​eut025.CrossRef
Metadata
Title
Outcome of slow pathway modulation for atrioventricular nodal reentrant tachycardia with 50 versus 30 watts—more power, more effect?
Authors
Dirk G. Dechering
Ruben Schleberger
Eva Greiser
Jannis Dickow
Julia Koebe
Gerrit Frommeyer
Stephan Willems
Lars Eckardt
Boris A. Hoffmann
Kristina Wasmer
Publication date
01-07-2018
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 2/2018
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0360-0

Other articles of this Issue 2/2018

Journal of Interventional Cardiac Electrophysiology 2/2018 Go to the issue